PUBLISHER: Euromonitor International | PRODUCT CODE: 1561981
PUBLISHER: Euromonitor International | PRODUCT CODE: 1561981
Analgesics in Hong Kong, China
Analgesics in Hong Kong remains on its path of recovery as the resumption of travel has led to an increase in retail tourism activity. Historically, tourist expenditure, particularly from mainland Chinese consumers, represented a substantial source of demand for analgesics in Hong Kong. The resurgence of inbound travel has certainly provided a tailwind for the category's recovery efforts. However, the delayed rebound in visitor spending has emerged as a dampening factor, moderating the overall p...
Euromonitor International's Analgesics in Hong Kong, China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
TABLE OF CONTENTS
List Of Contents And Tables
KEY DATA FINDINGS
2024 DEVELOPMENTS
- Sales of analgesics remain resilient in Hong Kong
- Topical analgesics/anaesthetic records further dynamic growth from low sales base
- Health and beauty specialists remains dominant distribution channel
PROSPECTS AND OPPORTUNITIES
- Analgesics may face competition from TCM formulations and vitamins and dietary supplements
- Demand for NSAIDs set to slow due to rising awareness of potential side effects
- Short-term challenges of alternatives purchased in neighbouring countries
CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN HONG KONG, CHINA
EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 1 Research Sources
